KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in NVS — Novartis AG
CIK 1021223
LOS ANGELES, CA
Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,259,872
-$98,075 QoQ
Shares Held
8,039
-9.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#561
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $148,204,577 across 14 Drug Manufacturers - General names. NVS ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,338 | $78,368,363 | |
| 2 | ABBV |
AbbVie Inc.
|
113,217 | $28,489,925 | |
| 3 | JNJ |
Johnson & Johnson
|
57,018 | $14,480,861 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,634 | $8,305,469 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
50,176 | $6,339,235 | |
| 6 | AMGN |
Amgen Inc
|
11,431 | $4,139,392 | |
| 7 | AZN |
Astrazeneca PLC
|
21,789 | $4,131,630 | |
| 8 | NVO |
Novo Nordisk A S
|
28,829 | $1,382,062 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,259,872 | 8,039 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,357,947 | 8,890 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,209,671 | 8,774 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,160,828 | 9,052 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,098,770 | 9,080 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,006,107 | 9,025 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $925,418 | 9,510 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $1,138,698 | 9,900 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,088,553 | 10,225 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,024,757 | 10,594 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,137,225 | 11,263 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,431,947 | 14,058 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,610,422 | 15,959 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,425,080 | 15,490 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,435,099 | 15,819 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,096,064 | 14,420 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,293,731 | 15,305 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,305,544 | 14,878 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,319,922 | 15,090 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,303,491 | 15,939 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,414,767 | 15,506 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,335,625 | 15,625 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,556,395 | 16,482 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,473,972 | 16,950 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,301,628 | 14,903 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,583,287 | 19,203 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||